• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对意大利疫苗接种效果和 SARS-CoV-2 谱系的定量评估的稳健性分析。

Robustness analysis for quantitative assessment of vaccination effects and SARS-CoV-2 lineages in Italy.

机构信息

ICT4Life srl, Perugia, Italy.

Department of Engineering, University of Perugia, Perugia, Italy.

出版信息

BMC Infect Dis. 2022 Apr 29;22(1):415. doi: 10.1186/s12879-022-07395-2.

DOI:10.1186/s12879-022-07395-2
PMID:35488251
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9051820/
Abstract

BACKGROUND

In Italy, the beginning of 2021 was characterized by the emergence of new variants of SARS-CoV-2 and by the availability of effective vaccines that contributed to the mitigation of non-pharmaceutical interventions and to the avoidance of hospital collapse.

METHODS

We analyzed the COVID-19 propagation in Italy starting from September 2021 with a Susceptible-Exposed-Infected-Recovered (SEIR) model that takes into account SARS-CoV-2 lineages, intervention measures and efficacious vaccines. The model was calibrated with the Bayesian method Conditional Robust Calibration (CRC) using COVID-19 data from September 2020 to May 2021. Here, we apply the Conditional Robustness Analysis (CRA) algorithm to the calibrated model in order to identify model parameters that most affect the epidemic diffusion in the long-term scenario. We focus our attention on vaccination and intervention parameters, which are the key parameters for long-term solutions for epidemic control.

RESULTS

Our model successfully describes the presence of new variants and the impact of vaccinations and non-pharmaceutical interventions in the Italian scenario. The CRA analysis reveals that vaccine efficacy and waning immunity play a crucial role for pandemic control, together with asymptomatic transmission. Moreover, even though the presence of variants may impair vaccine effectiveness, virus transmission can be kept low with a constant vaccination rate and low restriction levels.

CONCLUSIONS

In the long term, a policy of booster vaccinations together with contact tracing and testing will be key strategies for the containment of SARS-CoV-2 spread.

摘要

背景

2021 年初,意大利出现了 SARS-CoV-2 的新变种,并且有了有效的疫苗,这有助于减轻非药物干预措施的影响,避免医院崩溃。

方法

我们从 2021 年 9 月开始,使用考虑了 SARS-CoV-2 谱系、干预措施和有效疫苗的易感-暴露-感染-恢复(SEIR)模型来分析意大利的 COVID-19 传播情况。该模型使用贝叶斯条件稳健校准(CRC)方法,利用 2020 年 9 月至 2021 年 5 月的 COVID-19 数据进行校准。在这里,我们将条件稳健性分析(CRA)算法应用于校准模型,以确定在长期情景下对流行病扩散影响最大的模型参数。我们关注的是疫苗接种和干预参数,这些参数是长期控制流行病的关键参数。

结果

我们的模型成功地描述了新变种的出现以及疫苗接种和非药物干预措施在意大利的影响。CRA 分析表明,疫苗效力和免疫力衰减对于控制大流行起着至关重要的作用,与无症状传播一起。此外,即使变种的存在可能会降低疫苗的有效性,但如果保持高疫苗接种率和低限制水平,病毒传播仍可以保持较低水平。

结论

从长远来看,加强疫苗接种、接触者追踪和检测将是控制 SARS-CoV-2 传播的关键策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a6/9052593/aedfa7cb6969/12879_2022_7395_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a6/9052593/5a00cd1a8233/12879_2022_7395_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a6/9052593/16a0c658565e/12879_2022_7395_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a6/9052593/9befa97cf32e/12879_2022_7395_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a6/9052593/cbe3f48e2352/12879_2022_7395_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a6/9052593/9aaed285f23b/12879_2022_7395_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a6/9052593/9473b131f09d/12879_2022_7395_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a6/9052593/aedfa7cb6969/12879_2022_7395_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a6/9052593/5a00cd1a8233/12879_2022_7395_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a6/9052593/16a0c658565e/12879_2022_7395_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a6/9052593/9befa97cf32e/12879_2022_7395_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a6/9052593/cbe3f48e2352/12879_2022_7395_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a6/9052593/9aaed285f23b/12879_2022_7395_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a6/9052593/9473b131f09d/12879_2022_7395_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a6/9052593/aedfa7cb6969/12879_2022_7395_Fig7_HTML.jpg

相似文献

1
Robustness analysis for quantitative assessment of vaccination effects and SARS-CoV-2 lineages in Italy.针对意大利疫苗接种效果和 SARS-CoV-2 谱系的定量评估的稳健性分析。
BMC Infect Dis. 2022 Apr 29;22(1):415. doi: 10.1186/s12879-022-07395-2.
2
A Modeling Study on Vaccination and Spread of SARS-CoV-2 Variants in Italy.意大利新冠病毒变异株疫苗接种与传播的建模研究
Vaccines (Basel). 2021 Aug 17;9(8):915. doi: 10.3390/vaccines9080915.
3
Mathematical Modeling and Robustness Analysis to Unravel COVID-19 Transmission Dynamics: The Italy Case.用于揭示新冠病毒传播动态的数学建模与稳健性分析:意大利案例
Biology (Basel). 2020 Nov 11;9(11):394. doi: 10.3390/biology9110394.
4
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
5
Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland.接种疫苗和非药物干预措施对瑞士 SARS-CoV-2 动力学的影响。
Epidemics. 2022 Mar;38:100535. doi: 10.1016/j.epidem.2021.100535. Epub 2021 Dec 14.
6
The potential clinical impact of implementing different COVID-19 boosters in fall 2022 in the United States.2022 年秋季在美国实施不同 COVID-19 加强针的潜在临床影响。
J Med Econ. 2022 Jan-Dec;25(1):1127-1139. doi: 10.1080/13696998.2022.2126127.
7
Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy.意大利疫苗接种推广、新冠病毒变异株及非药物干预措施需求的建模
Nat Med. 2021 Jun;27(6):993-998. doi: 10.1038/s41591-021-01334-5. Epub 2021 Apr 16.
8
Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC].不同 COVID-19 疫苗组合在健康个体中的安全性和免疫原性评估:一项随机、设盲、对照的 3 期临床试验 [PRIBIVAC] 的研究方案。
Trials. 2022 Jun 16;23(1):498. doi: 10.1186/s13063-022-06345-2.
9
SARS-CoV-2 transmissibility compared between variants of concern and vaccination status.关注变异株与疫苗接种状况之间的新冠病毒传播性比较。
Brief Bioinform. 2022 Mar 10;23(2). doi: 10.1093/bib/bbab594.
10
Untangling the changing impact of non-pharmaceutical interventions and vaccination on European COVID-19 trajectories.厘清非药物干预措施和疫苗接种对欧洲 COVID-19 传播轨迹的变化影响。
Nat Commun. 2022 Jun 3;13(1):3106. doi: 10.1038/s41467-022-30897-1.

引用本文的文献

1
Excess Mortality among Physicians and Dentists during COVID-19 in Italy: A Cross-Sectional Study Related to a High-Risk Territory.意大利新冠疫情期间医生和牙医的超额死亡率:一项与高风险地区相关的横断面研究
Healthcare (Basel). 2022 Sep 4;10(9):1684. doi: 10.3390/healthcare10091684.

本文引用的文献

1
Risk assessment of COVID-19 epidemic resurgence in relation to SARS-CoV-2 variants and vaccination passes.与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株和疫苗接种通行证相关的2019冠状病毒病疫情卷土重来的风险评估
Commun Med (Lond). 2022 Mar 3;2:23. doi: 10.1038/s43856-022-00084-w. eCollection 2022.
2
Low case numbers enable long-term stable pandemic control without lockdowns.低病例数使得在不实施封锁的情况下也能实现长期稳定的疫情控制。
Sci Adv. 2021 Oct 8;7(41):eabg2243. doi: 10.1126/sciadv.abg2243.
3
Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.
卡塔尔:BNT162b2 疫苗对 SARS-CoV-2 感染的保护作用逐渐减弱。
N Engl J Med. 2021 Dec 9;385(24):e83. doi: 10.1056/NEJMoa2114114. Epub 2021 Oct 6.
4
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.辉瑞-BioNTech 新冠疫苗接种 6 个月后免疫体液反应逐渐减弱。
N Engl J Med. 2021 Dec 9;385(24):e84. doi: 10.1056/NEJMoa2114583. Epub 2021 Oct 6.
5
New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status - New York, May 3-July 25, 2021.按疫苗接种状况划分的2021年5月3日至7月25日纽约市成年人新冠病毒新增病例及住院情况
MMWR Morb Mortal Wkly Rep. 2021 Sep 17;70(37):1306-1311. doi: 10.15585/mmwr.mm7037a7.
6
A Modeling Study on Vaccination and Spread of SARS-CoV-2 Variants in Italy.意大利新冠病毒变异株疫苗接种与传播的建模研究
Vaccines (Basel). 2021 Aug 17;9(8):915. doi: 10.3390/vaccines9080915.
7
A look into the future of the COVID-19 pandemic in Europe: an expert consultation.欧洲新冠疫情的未来展望:一次专家咨询
Lancet Reg Health Eur. 2021 Sep;8:100185. doi: 10.1016/j.lanepe.2021.100185. Epub 2021 Jul 30.
8
Dynamics of the COVID-19 epidemic in Ireland under mitigation.爱尔兰在采取缓解措施下的新冠疫情动态。
BMC Infect Dis. 2021 Aug 3;21(1):735. doi: 10.1186/s12879-021-06433-9.
9
On the Environmental Determinants of COVID-19 Seasonality.论新冠疫情季节性的环境决定因素
Geohealth. 2021 Jun 1;5(6):e2021GH000413. doi: 10.1029/2021GH000413. eCollection 2021 Jun.
10
Emergence and Spread of SARS-CoV-2 Lineages B.1.1.7 and P.1 in Italy.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)谱系B.1.1.7和P.1在意大利的出现与传播。
Viruses. 2021 Apr 29;13(5):794. doi: 10.3390/v13050794.